Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Histopathology and Laboratory Analysis Services

Active

Federal

Response Deadline08/19/2026, 04:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract seeks specialized histopathological evaluation services for kidney tissues derived from efficacy studies, requiring comprehensive laboratory analysis that includes tissue staining, detailed injury scoring, and digital pathology reporting to ensure accurate and reproducible results. The work demands expertise in interpreting morphological changes in renal tissues and delivering standardized, high-quality digital reports that support regulatory and research objectives. This is a subcontract solicited by the National Institutes of Health under the Department of Health and Human Services, classified under NAICS code 621511 for medical and diagnostic laboratories. The solicitation was posted on August 4, 2026, with a response deadline of August 19, 2026, and no set-aside provisions are specified. Performance location and point of contact details are not provided, and the full terms and requirements must be accessed through the official SAM.gov portal linked in the posting.

General Info

Histopathological evaluation of kidney tissues with staining, scoring, and digital reporting for NIH-funded research.

Agency

Department Of Health And Human Services → National Institutes Of Health OlaoView Agency

NAICS

621511 - Medical LaboratoriesView NAICS

Place of Performance

MD

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedAug 4

subcontract

Response DeadlineAug 19

Submission deadline

Response Deadline

08/19/2026, 04:00:00 PM UTCin 14 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Health And Human Services → National Institutes Of Health Olao

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Perform histopathological evaluation of kidney tissues from efficacy studies, including staining, injury scoring, and digital pathology reporting.

Similar Contracts

Same NAICS industry code

Reasonable Suspicion and Post-Accident TestingNueces County is seeking a subcontractor to provide urgent drug and alcohol testing services for reasonable suspicion and post-accident situations, with a requirement for round-the-clock availability and rapid result turnaround. The contract supports safety-critical operations by ensuring timely and reliable testing in high-stakes scenarios, where delays could impact compliance, investigations, or public safety. Responses are due by August 27, 2026, and the work falls under NAICS code 621511, indicating laboratory services related to medical diagnostics. The solicitation is open to qualified vendors capable of meeting strict time-sensitive demands, with no set-aside provisions specified. Performance is expected to be coordinated within Texas, though precise location details are not provided, and interested parties must submit proposals through the published public procurement portal.

POSTED

about 23 hours ago

DEADLINE

Random Drug and Alcohol Testing Program ManagementNueces County seeks a contractor to manage a comprehensive random drug and alcohol testing program for approximately 750 employees, encompassing the full lifecycle of the testing process including random selection, scheduling, specimen collection, laboratory analysis, and ongoing compliance reporting. The contract requires consistent adherence to regulatory standards and accurate documentation to ensure program integrity and legal compliance. The solicitation is issued as a subcontract with a NAICS code of 621511, indicating a focus on medical and diagnostic laboratories, and the response deadline is set for August 27, 2026. Although specific location details for performance or contact information are not provided, the contracting entity is Nueces County in Texas, and interested parties must submit proposals through the designated public procurement portal before the stated deadline.

POSTED

about 23 hours ago

DEADLINE

Pre-Employment Drug Testing ServicesNueces County is seeking a subcontractor to provide comprehensive pre-employment drug testing services for safety-sensitive employees, fully compliant with U.S. Department of Transportation regulations. The scope includes specimen collection, laboratory analysis, and Medical Review Officer review to ensure accurate, legally defensible results. All services must adhere strictly to federal DOT standards for testing procedures, chain of custody, and reporting protocols. The contract is solicited as a subcontract under NAICS code 621511, and responses are due by August 27, 2026. The services will be performed in Texas, though the exact location for performance is not specified. This procurement is open to qualified vendors capable of delivering timely, secure, and regulatory-compliant drug testing solutions to support workforce safety in safety-sensitive positions.

POSTED

about 23 hours ago

DEADLINE

PR Needed NEW Request / Thyroid Molecular Tests - THYROSEQ 5 year contract

Solicitation # 36C26026Q0888

The Department of Veterans Affairs through the 260-NETWORK Contract Office 20 is seeking proposals for a five-year contract to provide molecular testing services for thyroid nodule fine needle aspiration specimens using the THYROSEQ platform. This service supports the clinical assessment of indeterminate thyroid nodules by detecting genetic alterations linked to thyroid malignancy, thereby improving diagnostic accuracy and guiding patient management. The solicitation, numbered 36C26026Q0888, was posted on August 4, 2026, with responses due by August 24, 2026, and is not subject to any small business set-asides under NAICS code 621511 for medical laboratories. The contract will be managed from the office located in Vancouver, Washington, with performance expected primarily in Seattle, Washington. Primary point of contact is Hector D. Baltazar, Contracting Specialist, reachable at hector.baltazar@va.gov, with James Harris as the secondary contact for additional inquiries.

260-NETWORK Contract Office 20 (36C260)

POSTED

DEADLINE

Supplying and Delivering Two (2) Mobile Laboratory Setups to the US Embassy Kampala, Uganda

Solicitation # 19GE5026Q0129

The U.S. Department of State’s Regional Procurement Support Office in Frankfurt plans to award a sole source firm fixed price contract to DST innovation GmbH of Germany for the supply and delivery of two mobile laboratory setups to the U.S. Embassy in Kampala, Uganda. These labs are designed to enable rapid response to biological threats and disease outbreaks and are based on the proven mobile laboratory system developed by the Bundeswehr Institute of Microbiology in Munich. The setup includes an air-transportable inflatable tent, mobile gloveboxes, sample collection and processing equipment, PCR and ELISA instrumentation, light microscopy tools, personal protective equipment including PAPRs, solar power units, refrigeration and freezing units, an autoclave, water purification systems, ruggedized transportation cases, and a full complement of consumables and IT equipment. DST innovation is the only entity capable of providing this exact configuration due to its direct technical lineage from the Bundeswehr Institute and its proven deployment in regional countries such as Tanzania, Burundi, and Zambia. The decision to proceed on a sole source basis is grounded in the necessity for interoperability with existing regional diagnostic systems, standardized reagents used by the Ugandan Ministry of Health, and established operational protocols that ensure safe and effective outbreak response. Utilizing identical equipment already in use across neighboring countries minimizes logistical challenges, enhances data comparability, supports joint exercises, and reduces response times during critical public health emergencies. Any deviation from this specific configuration could compromise mission success and safety. The government is soliciting capability statements from other potential sources solely to confirm there are no other capable providers, with submissions due by August 15, 2026, at 11:59 pm Central European Summer Time via email to walkerak@state.gov. The contract award will proceed as sole source unless compelling evidence is presented demonstrating that another supplier can meet all specifications identically and reliably.

Acquisitions - Rpso Frankfurt

POSTED

DEADLINE

Q301--Cytopathology and Next Generation Sequencing Testing

Solicitation # 36C24226Q0875

The Department of Veterans Affairs Network Contracting Office 2 is soliciting offers to establish an Indefinite Delivery Indefinite Quantity (IDIQ) contract for comprehensive molecular diagnostic testing using next-generation sequencing to evaluate thyroid nodules with indeterminate fine-needle aspiration cytology. The goal is to improve clinical decision-making by providing scientifically validated genomic insights that enhance diagnostic accuracy, reduce the incidence of unnecessary surgical interventions, and enable timely, personalized care for Veterans at risk. This contract will support the delivery of clinically integrated testing services that align with evolving standards in cytopathology and molecular diagnostics. The solicitation, numbered 36C24226Q0875, was posted on August 4, 2026, with proposals due by August 21, 2026, and is classified under NAICS code 621511 for medical and diagnostic laboratories. Offerors must be prepared to perform services primarily at the Northport, New York location, with the contracting office located in Albany, New York. The primary point of contact is Contracting Officer Mariangie Rivera, reachable via email at Mariangie.Rivera@va.gov. This procurement is structured as a combined solicitation and does not specify a small business set-aside, indicating open competition across eligible industry participants seeking to provide advanced molecular testing solutions to the Veterans Health Administration.

242-NETWORK Contract Office 02 (36C242)

POSTED

DEADLINE

PINE RIDGE IHS LAB-ISTAT REAGENT SUPPLIES

Solicitation # 75H70626Q00212

This contract is a combined synopsis and solicitation for commercial goods issued under FAR Subpart 12.6 by the Great Plains Area Indian Health Service, seeking a firm-fixed-price award for the supply of I-STAT reagents to the Pine Ridge Indian Health Service Hospital Laboratory in South Dakota. The solicitation, numbered 75H70626Q00212, is set aside 100% for Indian Small Business Economic Enterprise (ISBEE) with a NAICS code of 621511 and a size standard of 200 employees, requiring offerors to self-certify as Indian-owned firms. The total contract value is $32,727.00 for a one-year period from the date of award, with deliveries scheduled to begin on September 15, 2026, and conclude on September 14, 2027. Products must include Abbott-certified reagents, calibrators, and controls such as TRICONTROL levels 1–3, TROPONIN cartridges, and other specific items, with shipments required to include only new, unrefurbished items and no gray market or counterfeit parts. All offerings must comply with strict cold-chain standards, zero temperature excursions, and longest available expiration dating, with single-lot deliveries and precise labeling required for acceptance at the delivery site. Quotes must be submitted via email to Patricia Thompson by 12:00 PM MST on August 13, 2026, on company letterhead with signed and dated documentation including completed SF18 and IEE Representation forms, a technical description of goods, warranty terms, itemized pricing, remittance details, past performance references, and all mandatory representations and certifications per FAR 52.212-3 and SAM.gov registration requirements. Evaluation will follow the Lowest Price Technically Acceptable (LPTA) method, with technical acceptability in three critical areas: continuous supply capability (95% on-time delivery, 98% product acceptance, 100% shelf-life compliance, no cold-chain breaches), demonstrable past performance (rated acceptable/unacceptable with a single unacceptable disqualifying the offer), and the lowest evaluated price. Compliance with the Invoice Processing Platform (IPP) is mandatory for post-award invoicing under HHSAR 352.232-71, and offerors must have a valid UEI and be registered in SAM

Great Plains Area Indian Health Svc

POSTED

DEADLINE

Rapid DNA Testing ServicesThe contract seeks a subcontractor to provide Rapid DNA collection and analysis services that meet AABB accreditation standards, with the explicit requirement that results not be uploaded to CODIS. This service is intended to deliver timely, accurate, and accredited DNA testing in settings where federal DNA database inclusion is prohibited, ensuring compliance with both technical and regulatory protocols. The provider must demonstrate the ability to perform end-to-end DNA processing—from sample collection through analysis—with verified adherence to quality assurance benchmarks aligned with AABB guidelines. The solicitation is classified as a subcontract under the NAICS code 621511 and is managed by the Omas Strategic Buying Center under the Department of Health and Human Services. The opportunity was posted on August 2, 2026, with responses due by August 10, 2026. While specific performance locations and point of contact details are not provided, the work is anticipated to support federal or partner operations requiring rapid DNA results without federal database integration. Bidders must be prepared to meet stringent quality controls, maintain full documentation of processes, and ensure seamless integration into existing workflows without leveraging CODIS infrastructure.

Omas Strategic Buying Center - HHS Mission

POSTED

DEADLINE

Medical Laboratory Testing – MRD Analysis via clonoSEQ AssayThe contract calls for the performance of 100 annual Measurable Residual Disease tests using the proprietary clonoSEQ assay for Veterans diagnosed with hematologic malignancies. Each test must be conducted using an FDA-cleared and CLIA-validated methodology to ensure clinical accuracy and regulatory compliance. The work is structured as a subcontract under the Department of Veterans Affairs, specifically managed by the 244-NETWORK Contract Office 4, and falls under the NAICS code 621511 for medical laboratory services. The solicitation was posted on July 31, 2026, with a response deadline of August 10, 2026, indicating a tight procurement timeline. While the place of performance and point of contact details are not specified, the requirement emphasizes standardized, validated laboratory testing to support clinical decision-making for Veterans, with no set-aside provisions identified.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

Q301--Lab Testing Services - clonoSEQ Measurable Residual Disease Test Pittsburgh VA Medical Center - Pittsburgh, PA

Solicitation # 36C24426Q0855

The Department of Veterans Affairs’ Network Contracting Office 4 intends to award a sole source contract to Adaptive Biotechnologies Corporation for the provision of clonoSEQ Measurable Residual Disease (MRD) testing services at the Pittsburgh VA Medical Center. This action is justified under FAR 6.103-1 because Adaptive Biotechnologies is the exclusive provider of the clonoSEQ assay, a proprietary, FDA-cleared, and CLIA-validated molecular test used to detect MRD in patients with multiple myeloma, B-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, diffuse large B-cell lymphoma, and other lymphoid malignancies. The contract will use simplified acquisition procedures, be firm fixed price, and span a five-year period with an annual quantity of 100 tests. The solicitation number is 36C24426Q0855, and the NAICS code is 621511 with a size standard of $41.5 million. Any interested party may submit a capability statement prior to the response deadline of August 10, 2026, at 8:00 AM Eastern Standard Time, but the Government retains full discretion to proceed without competition based on the unique nature of the technology and the absence of viable alternatives. Responses must include the company name, SAM UEI number, address, point of contact details, business size, and evidence demonstrating the ability to perform the service, including relevant experience, contract numbers, dollar amounts, performance periods, and customer contacts. All submissions must be emailed to Mickeya Linzie at mickeya.linzie@va.gov and must clearly state whether the respondent is the direct provider or an authorized reseller. No submissions will be accepted after the deadline, and all information provided becomes the property of the Government.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

Drug and Alcohol Testing ServicesThe contract requires the provision of drug and alcohol testing services for construction personnel in alignment with SAMHSA guidelines, ensuring compliance with federal standards for workplace safety. Testing must include EMIT screening as an initial method followed by definitive GC/MS confirmation to ensure accurate and legally defensible results. The scope of work is specifically targeted at personnel involved in construction activities under the purview of the Professional Services Department of the Los Angeles Community College District, with all testing protocols required to meet the highest regulatory benchmarks for accuracy, chain of custody, and reporting. The solicitation is classified as a subcontract with a response deadline of September 1, 2026, and is associated with NAICS code 621511, indicating clinical laboratory services. The place of performance and agency location are not precisely defined in the data, but the contracting entity operates within California. There is no set-aside designation specified, meaning the contract is open to all eligible vendors. The official posting is accessible via the provided vendor portal link, and prospective bidders must ensure full adherence to SAMHSA compliance requirements, laboratory accreditation standards, and timely submission of proposed services and pricing by the stated deadline.

Professional Services Department of Los Angeles Community College District

POSTED

DEADLINE

Newborn Screening Laboratory Testing ServicesThis contract is for the provision of newborn screening laboratory testing services required by state mandates, encompassing first, second, and repeat screenings for metabolic, genetic, and congenital disorders using specialized diagnostic assays. The work involves highly precise laboratory procedures to detect rare but serious conditions in newborns, ensuring early intervention and improved health outcomes. All testing must meet stringent quality and regulatory standards to guarantee accuracy and timeliness, with results delivered promptly to healthcare providers. The contract is a subcontract advertised by the Navajo Area Indian Health Service under the U.S. Department of Health and Human Services, with performance expected to occur in the 86503 zip code area. It falls under NAICS code 621511 for medical and diagnostic laboratories and has a response deadline of August 14, 2026. The solicitation does not specify a set-aside type or point of contact, and the location details for the agency’s office are incomplete, but the place of performance is clearly defined to ensure services are delivered within the designated service region.

Navajo Area Indian Health Svc

POSTED

DEADLINE

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

Supply of Research Reagents and DietsThe contract entails the supply of specialized research reagents and diets essential for preclinical disease modeling, including adenine-enriched diets, high-sucrose and high-fat diets, streptozotocin, and associated ancillary reagents required to induce and maintain metabolic and renal disease models in animal studies. These materials are critical for supporting biomedical research aimed at understanding chronic conditions such as diabetes, kidney disease, and metabolic syndrome under controlled experimental conditions. The reagents must meet strict quality and consistency standards to ensure reproducibility and validity of research outcomes across multiple investigative sites. This subcontract, issued under the National Institutes of Health under the Department of Health and Human Services, is classified under NAICS code 424690 for medical and dental equipment and supplies merchant wholesalers. The solicitation was posted on August 4, 2026, with a response deadline of August 19, 2026. Performance is expected to support research activities managed by federal entities, though specific locations for delivery or use are not detailed. Suppliers must be prepared to comply with federal procurement requirements, deliver reagents in appropriate formulations and quantities, and ensure traceability and documentation for all provided items to facilitate regulatory and scientific compliance.

Other Chemical and Allied Products Merchant Wholesalers

POSTED

DEADLINE

Efficacy Study – HSHFD+STZ-Induced Diabetic Kidney Disease ModelThe contract outlines a commissioned efficacy study to evaluate the impact of an NNMT inhibitor in a mouse model of diabetic kidney disease induced by a high-sodium, high-fat diet combined with streptozotocin. The study requires comprehensive metabolic monitoring throughout the treatment period, precise dosing regimens, and systematic collection of tissue samples for downstream analysis. Endpoint evaluation will include detailed assessment of renal function, histopathological changes, and molecular markers associated with disease progression and therapeutic response. All procedures must adhere to standardized protocols to ensure data reliability and reproducibility, with results intended to support further development of the inhibitor as a potential therapeutic agent. The work is being pursued under a subcontract agreement issued by the National Institutes of Health through the Department of Health and Human Services, classified under NAICS code 541690 for other scientific research and development services. The solicitation was posted on August 4, 2026, with a response deadline of August 19, 2026. The contract does not specify a place of performance or point of contact, and no set-aside provisions are indicated. The project is positioned as a critical preclinical step in advancing an NNMT-targeted intervention for diabetic kidney disease, with findings expected to inform future clinical translation and funding decisions.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Efficacy Study – Adenine Diet-Induced Kidney Disease ModelThe contract outlines a preclinical efficacy study to evaluate a NNMT inhibitor in a mouse model of adenine-induced chronic kidney disease, focusing on therapeutic assessment through controlled dosing, longitudinal monitoring, and systematic sample collection. The study requires detailed protocols for administering the inhibitor, tracking disease progression via biochemical and histological endpoints, and analyzing the resulting data to determine efficacy, with all procedures aligned to industry standards for preclinical research. The work is to be performed under a subcontract arrangement, with the National Institutes of Health under the Department of Health and Human Services as the overseeing entity, and is classified under NAICS code 541690, indicating it falls within other scientific research and development services. Responses are due by August 19, 2026, following a posting date of August 4, 2026.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Recovery and Breeding of Humanized NNMT MiceThe contract involves the recovery and breeding of approximately 50 male homozygous humanized NNMT mice through the thawing of cryopreserved sperm, followed by subsequent mating procedures to reestablish the colony. This includes full animal husbandry responsibilities such as proper housing, feeding, and monitoring for health and wellbeing, as well as genotyping to confirm genetic consistency and homozygosity across the cohort. Ongoing colony health maintenance is required to ensure disease-free status and reliable experimental outcomes, with all procedures aligned to standard laboratory animal care protocols. The work is classified under NAICS code 541940 and is structured as a subcontract under the National Institutes of Health, part of the Department of Health and Human Services, with a response deadline of August 19, 2026, and a posted date of August 4, 2026.

Veterinary Services

POSTED

DEADLINE

Shipping and Delivery to NCATS, Rockville, MD

Specialized Freight (except Used Goods) Trucking, Local

POSTED

DEADLINE

12-Month Reliance Complete Service Contract

Computer and Office Machine Repair and Maintenance

POSTED

DEADLINE

Remote Installation and Training Services

Computer Systems Design Services

POSTED

DEADLINE

Supply of Dedicated Windows 11 Professional Workstation

Electronic Computer Manufacturing

POSTED

DEADLINE

Supply of Automated Sample Management System (BioMicroLab VC384)

Analytical Laboratory Instrument Manufacturing

POSTED

DEADLINE

Evaluation of a Lead NNMT Inhibitor in Humanized M

Solicitation # 75N98026Q00941

The National Institutes of Health, Office of the Director, intends to award a non-competitive, firm-fixed price contract to GemPharmatech LLC for the evaluation of a lead NNMT inhibitor using a humanized nicotinamide N-methyltransferase mouse model, a model uniquely developed and maintained by GemPharmatech under prior NIH funding. This acquisition is conducted under streamlined commercial item procedures and is not expected to exceed the simplified acquisition threshold, with authority derived from FAR 12.603 and 41 U.S.C. 1901, and justified under the sole source exception for unique capabilities, as GemPharmatech is the only entity with the cryopreserved sperm and breeding resources necessary to regenerate the required mouse colony essential for generating scientifically relevant efficacy data due to the inhibitor's species-specific activity. The solicitation number is 75N98026Q00941, issued as a combined synopsis and solicitation without competitive procedures, and responses are due by August 19, 2026. The work falls under NAICS code 541714 for Research and Development in Biotechnology with a small business size standard of 1,000 employees, and this requirement is not set aside for small business. The contract will be managed by the NIH Office of Acquisitions based in Bethesda, Maryland, with the primary point of contact being Johnstona C. Johnston, reachable via email. All provisions and clauses follow those in effect through the Federal Acquisition Circular dated August 4, 2026, and the notice serves as the complete and only solicitation document; no additional written solicitation will be issued. The performance location is not specified beyond the federal agency's administrative details.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

Fisher Scientific Reagents and Consumable Materials for Cell Therapy Manufacturing

Solicitation # 26-008155

The National Institutes of Health Clinical Center plans to award a sole-source firm-fixed-price purchase order to Fisher Scientific for validated reagents and consumable materials essential to the manufacturing of FDA-regulated cell-based therapies used in NIH clinical trials. These materials have been rigorously validated and approved by the Center for Cellular Engineering’s Quality Assurance Department to ensure consistent quality, safety, and efficacy in producing cell therapies for patient care. Any substitution of these materials would necessitate extensive and costly revalidation of manufacturing processes, leading to significant delays and potential risks to ongoing clinical trials, making Fisher Scientific the only viable supplier capable of providing the required validated products and supporting documentation compliant with federal regulatory standards. The acquisition is authorized under FAR 13.106-1(b)(1)(i), which allows for single-source procurement when only one provider can meet the government’s specific requirements, and the value does not exceed the simplified acquisition threshold. The product service code is 6550, and the NAICS code is 325413, classifying the items as in-vitro diagnostic substances. Performance will occur at the NIH Clinical Center in Bethesda, Maryland. While this notice does not solicit bids or proposals, responsible parties may submit capability statements by August 13, 2026, at 6:00 p.m. Eastern Time, referencing POTS 26-008155, though the government retains full discretion to proceed without competition. All inquiries should be directed to Shasheshe Goolsby of the Hospital and Laboratory Support Division.

In-Vitro Diagnostic Substance Manufacturing

POSTED

DEADLINE

Annual Service and Maintenance Agreement for Agile

Solicitation # 75N98026Q00944

The National Institutes of Health, Office of the Director, Office of Acquisitions, is seeking proposals under solicitation number 75N98026Q00944 for an Annual Service and Maintenance Agreement for Agile, issued as a competitive combined synopsis and solicitation under FAR Subpart 12.6 for commercial items. The contract will be awarded on a firm-fixed-price basis to the offeror providing the best value to the government through full and open competition, with no set-aside restrictions, and the requirement is not expected to exceed the simplified acquisition threshold. The solicitation is governed by provisions and clauses in effect through the Federal Acquisition Circular effective August 3, 2026, and the North American Industry Classification System code is 811210, corresponding to Electronic and Precision Equipment Repair and Maintenance, with a small business size standard of $34.0 million in annual revenue. Proposals must be submitted by August 19, 2026, at 8:00 PM Eastern Time, following the instructions outlined in the solicitation document, which serves as the complete request for offers without a separate written solicitation. The place of performance and specific delivery details are not fully defined in the posting, but the contracting office is located in Bethesda, Maryland. All inquiries should be directed to John Johnston, the primary point of contact, reached at jaddua.johnston@nih.gov. The solicitation is accessible online through the SAM.gov portal, and offerors are expected to review all applicable terms and conditions prior to submission.

Electronic and Precision Equipment Repair and Maintenance

POSTED

DEADLINE